JL
Publicaties op Oncologisch.com
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as eerstelijns treatment for gevorderd squamous n...
Surufatinib in gevorderd neuroendocrine tumours: Final totale overleving from two randomised, double-blind, placebo-c...
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blin...
Thoracic Radiotherapy Improves the Survival in Patiënten met EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung ...
Surufatinib bij pancreatische NET: SANET-p fase III
Surufatinib bij extrapancreatische NET: SANET-ep fase III